Lansoprazole [Design Issues]

posted by drshiv – India, 2007-06-27 12:22 (6938 d 16:05 ago) – Posting: # 837
Views: 7,213

Hi Shankar,

See the FDA Industry Guidance on Statistical Issues in Bioavailability and Bioequivalence Studies. Download from FDA site. There are tables given to find out the number of subjects required in replicate design based on %CV.

drshiv

--
Edit: Full quote removed. Please see this post! [HS]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
133 visitors (0 registered, 133 guests [including 14 identified bots]).
Forum time: 04:28 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5